title: Discussing the zoster vaccine: an interview with Julie Gerberding, president of Merck Vaccines.
authors.forename: Julie
authors.initials: J
authors.lastname: Gerberding
mesh_terms: D006562:Herpes Zoster / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000627:therapeutic use*; D014645:Herpesvirus 3, Human / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D017735:Virus Latency / Q000187:drug effects*
chemical_list: D053061:Herpes Zoster Vaccine